Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 2,251 - 2,275 of 2,572

«
1
…
89
90
91
92
93
…
103
»

Pharmacokinetics of Anti-Cancer Agents in the CNS

Pharmacokinetics of Anti-Cancer Agents in the CNS

By: Tim Synold, PharmD

PK and PD Considerations in Early Phase Clinical Trials

PK and PD Considerations in Early Phase Clinical Trials

By: Timothy Synold, PharmD

PK and PD Considerations in Early Phase Clinical Trials

PK and PD Considerations in Early Phase Clinical Trials

By: Timothy Synold, PharmD

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

By: Timothy Synold, PharmD

Pharmacology I: What HemOnc Clinicians Must Know in Immunotherapy

Pharmacology I: What HemOnc Clinicians Must Know in Immunotherapy

By: Whitney E. Lewis, PharmD, BCOP

Leveraging NCODA Resources to Manage Patients on Oral Oncolytics

Leveraging NCODA Resources to Manage Patients on Oral Oncolytics

By: Yarelis Diaz Rohena, PharmD

Targeted Therapy in Prostate

Targeted Therapy in Prostate

By: Alan J. Koletsky, MD

Targeted Therapy in Prostate

Targeted Therapy in Prostate

By: Alan J. Koletsky, MD

Novel RT Approaches in Prostate Cancer

Novel RT Approaches in Prostate Cancer

By: Amar Kishan, MD

Novel RT Approaches in Prostate Cancer

Novel RT Approaches in Prostate Cancer

By: Amar Kishan, MD

Targeted Therapy for Prostate Cancer

Targeted Therapy for Prostate Cancer

By: Arif Hussain, MD

Updates in Prostate Cancer

Updates in Prostate Cancer

By: Chandler H. Park, MD, FACP

Updates in Prostate Cancer

Updates in Prostate Cancer

By: Chandler H. Park, MD, FACP

Prostate Cancer Update

Prostate Cancer Update

By: Chandler Park, MD, FACP

Prostate Cancer Update

Prostate Cancer Update

By: Chandler Park, MD, FACP

Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?

Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?

By: Chandler Park, MD, FACP

Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?

Updates in Prostate Cancer: Combination Therapy Becoming the Best Approach?

By: Chandler Park, MD, FACP

How I Treat Metastatic Prostate Cancer in 2023

How I Treat Metastatic Prostate Cancer in 2023

By: Chandler Park, MD, MSc, FACP

How I Treat Metastatic Prostate Cancer in 2023

How I Treat Metastatic Prostate Cancer in 2023

By: Chandler Park, MD, MSc, FACP

Prostate Cancer Management From Early Biochemical Recurrence to HRPC

Prostate Cancer Management From Early Biochemical Recurrence to HRPC

By: Daniel P Petrylak, MD

HRPC: How to Sequence Multiple Therapies

HRPC: How to Sequence Multiple Therapies

By: Daniel P. Petrylak, MD

Surfing Between Therapeutic Options for HRPC

Surfing Between Therapeutic Options for HRPC

By: Daniel Petrylak, MD

Prostate and Bladder Cancer

Prostate and Bladder Cancer

By: Daniel Petrylak, MD

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

By: Daniel Petrylak, MD

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

Prostate Cancer: Targeted, Hormonal & Novel Pathways in mCRPC

By: Daniel Petrylak, MD

«
1
…
89
90
91
92
93
…
103
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing